Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAIDs or acid suppressants?
Abstract
Objective: To measure the extent to which risks of oesophageal cancers associated with gastro-oesophageal reflux (GOR) are modified by common factors including smoking, non-steroidal anti-inflammatory drugs (NSAIDs) and acid suppressant medications. Design and setting: Population-based case–control study. Participants: Cases were patients with oesophageal (OAC; n = 365) or gastro-oesophageal junction (GOJAC; n = 426) adenocarcinomas, or squamous cell carcinomas (OSCC; n = 303). Controls were sampled from a population register (n = 1580). Main outcome measure: Odds ratio and 95% confidence interval. Results: Frequent (at least weekly) symptoms of GOR were associated with significant 6.4-fold, 4.6-fold and 2.2-fold increased risks of OAC, GOJAC and OSCC, respectively. Under models examining effects of combined exposure, patients with frequent GOR symptoms who were also heavy smokers had markedly higher OAC risks (OR = 12.3, 95% CI 6.3 to 24.0) than those with frequent GOR who did not smoke (OR = 6.8, 95% CI 3.6 to 12.9). Similar patterns were observed for GOJAC and OSCC. Among people with frequent GOR symptoms, regular use of aspirin/NSAIDs was associated with almost two-thirds lower OAC risks (OR = 4.8, 95% CI 2.5 to 9.2) than non-users (13.9, 95% CI 6.5 to 30.0). In contrast, among those with frequent GOR symptoms, users of acid suppressants had similar OAC risks (OR 7.8, 95% CI 5.2 to 11.8) to non-users (OR 5.3, 95% CI 3.2 to 9.0). Conclusions: People experiencing frequent GOR symptoms have markedly increased risks of OAC and GOJAC, and this effect may be greater amongst smokers. Use of aspirin and NSAIDs, but not acid suppressants, significantly reduced the risks of oesophageal cancers associated with GOR.Keywords
This publication has 41 references indexed in Scilit:
- Chemoprevention of Oesophageal Cancer and the AspECT Trial2009
- Relation of smoking status to a panel of inflammatory markers: The Framingham offspringAtherosclerosis, 2008
- Prevalence of Symptoms and Use of Medication for Gastroesophageal Reflux in an Australian CommunityWorld Journal of Surgery, 2008
- Time Trends of Gastroesophageal Reflux Disease: A Systematic ReviewClinical Gastroenterology and Hepatology, 2007
- Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinomaCancer, 2003
- Utility of Endoscopic Screening for Upper Gastrointestinal AdenocarcinomaJAMA, 2000
- The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardiaInternational Journal of Cancer, 2000
- The Relation of Gastroesophageal Reflux Disease and Its Treatment to Adenocarcinomas of the Esophagus and Gastric CardiaJAMA, 1995
- Increasing incidence of both major histological types of esophageal carcinomas among men in SwedenInternational Journal of Cancer, 1993
- Tobacco, alcohol intake, and diet in relation to adenocarcinoma of the esophagus and gastric cardiaCancer Causes & Control, 1993